TrialVaccine2016

A phase 1, randomized, controlled dose-escalation study of EP-1300 polyepitope DNA vaccine against Plasmodium falciparum malaria administered via electroporation.

Paul Spearman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.